TNXP EBITDA
Tonix Pharmaceuticals Holding Corp · EBITDA
TNXP EBITDA
Latest reported-$157.54Mperiod ending
TNXP TTM EBITDA (-$21.13K → -$157.54M)
TTM EBITDA
High-resolution chart · PNG
TNXP ebitda history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | EBITDA (USD) |
|---|---|
| -157,542,999 | |
| -145,398,999 | |
| -122,095,999 | |
| -97,285,999 | |
| -79,440,000 | |
| -129,222,000 | |
| -126,615,000 | |
| -131,064,000 | |
| -144,120,000 | |
| -93,984,000 | |
| -112,367,000 | |
| -117,150,000 | |
| -119,120,000 | |
| -114,723,000 | |
| -108,965,000 | |
| -107,647,000 | |
| -97,436,000 | |
| -97,944,000 | |
| -92,320,000 | |
| -79,810,000 | |
| -73,283,000 | |
| -63,923,000 | |
| -50,484,000 | |
| -42,197,000 | |
| -38,092,000 | |
| -29,805,000 | |
| -28,802,000 | |
| -27,712,000 | |
| -25,354,000 | |
| -25,583,000 | |
| -26,268,000 | |
| -24,152,000 | |
| -24,443,000 | |
| -23,079,000 | |
| -21,173,000 | |
| -23,089,000 | |
| -24,845,000 | |
| -29,907,000 | |
| -38,797,000 | |
| -44,689,000 | |
| -50,349,000 | |
| -52,284,000 | |
| -48,001,000 | |
| -43,653,000 | |
| -37,846,000 | |
| -32,129,000 | |
| -27,620,000 | |
| -22,341,000 | |
| -18,001,000 | |
| -14,039,000 | |
| -10,871,000 | |
| -7,168,913 | |
| -5,811,179 | |
| -5,576,355 | |
| -4,690,343 | |
| -8,057,605 | |
| -7,339,471 | |
| -5,845,774 | |
| -5,246,225 | |
| -1,882,865 | |
| -874,418 | |
| -523,341 | |
| -17,724 | |
| -15,391 | |
| -14,319 | |
| -25,825 | |
| -30,867 | |
| -30,533 | |
| -31,572 | |
| -22,953 | |
| -21,134 |